Loading…
Based on limited metadata with no full letter text available, Farma Glow, a drug manufacturer, received an FDA Warning Letter on October 9, 2018. Without access to the specific subject line or violation details, the precise nature of the regulatory concerns cannot be determined from the available information. The warning falls under FDA's drug product oversight and enforcement authority. A complete review of the full warning letter would be necessary to identify the specific violations and required corrective actions.